+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Asia-Pacific Omega-3 PUFA Market - Growth, Trends, and Forecast (2020 - 2025)

  • PDF Icon

    Report

  • 90 Pages
  • April 2020
  • Region: Asia Pacific
  • Mordor Intelligence
  • ID: 5012101
UP TO OFF until Mar 31st 2024
The Asia-Pacific Omega-3 PUFA Market is projected to grow at a CAGR of 8.2% during the forecast period.

Rising disposable income in developing regions, such as the Asia Pacific is also one of the major reasons for the increase in spending on any food or supplement, which is positioned as healthy including omega-3 supplements.

Manufacturers and suppliers involved actively in the supply chain of omega-3 in the Asia-Pacific region are making strategic efforts to ensure a gradual flow of information regarding the health benefits associated with omega-3 enriched diets, which has largely and positively affected the sales of omega-3 ingredients in the developing regions.

Key Market Trends

Increased Application in Dietary Supplements

Consumers are understanding the importance of incorporating supplements in their
regular diets. Omega-3 containing dietary supplements are proving to be a major attraction for almost every manufacturer, owing to their assistance in maintaining bone health, heart health and preventing hypertension, breast, prostate, and colon cancer, and even skin and eye-related disorders in both the geriatric as well as younger population segments. Healthcare professionals and physicians are also recommending omega-3 dietary supplements to their patients. This can be attributed to the robust growth of the omega-3 product market over the forecast period

China Holds the Maximum Share in Market

China is the largest market owing to the strong manufacturing base, increasing middle-class population, disposable income, and health awareness are fueling the consumption of EPA and DHA ingredients in China. The high birth rate and the recent abolition of the one-child policy in China are expected to fuel the demands for DHA-based ingredients for infant nutritional formulae. Infant formulae followed by dietary supplements are two major application areas in the Chinese EPA and DHA market. The dietary supplements sector in the China marketplace is expected to emerge as a lucrative application sector for EPA and DHA ingredients amid an increase in discretionary spending.

Competitive Landscape

The Asia-Pacific Omega-3 PUFA Market is consolidated and major companies hold maximum share in the market. Emphasis is given on the merger, expansion, acquisition, and partnership of the companies along with new product development as strategic approaches adopted by the leading companies to boost their brand presence among consumers. The key players in the market are BASF SE, Corbion N.V, and Koninklijke DSM N.V. among others.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
3.1 Market Overview
4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Docosahexaenoic Acid (DHA)
5.1.2 Eicosapentaenoic Acid (EPA)
5.1.3 Alpha-Linolenic Acid (ALA)
5.1.4 Others
5.2 By Application
5.2.1 Food and Beverages
5.2.1.1 Functional Food and Beverages
5.2.1.2 Infant Nutrition
5.2.2 Dietary Supplements
5.2.3 Pharmaceuticals
5.2.4 Animal Nutrition
5.3 Geography
5.3.1 Asia Pacific
5.3.1.1 China
5.3.1.2 Japan
5.3.1.3 India
5.3.1.4 Australia
5.3.1.5 Rest of Asia Pacific
6 COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 BASF SE
6.4.2 Corbion N.V
6.4.3 Koninklijke DSM N.V.
6.4.4 Croda International Plc
6.4.5 KD Pharma Group
6.4.6 Clover Corporation Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BASF SE
  • Corbion N.V
  • Koninklijke DSM N.V.
  • Croda International Plc
  • KD Pharma Group
  • Clover Corporation Ltd

Methodology

Loading
LOADING...